Showing results (191-200 of 208) with videos related to

Sort By:
Pageof 21
Genome Medicine|May 5, 2016
Identification of the BRD1 interaction network and its impact on mental disorder riskTue Fryland, Jane H Christensen, Jonatan Pallesen, et al.
Molecular Genetics and Metabolism|July 17, 2012
Biochemical screening of 504,049 newborns in Denmark, the Faroe Islands and Greenland--experience and development of a routine program for expanded newborn screeningAllan Meldgaard Lund, David Michael Hougaard, Henrik Simonsen, et al.
Frontiers in Molecular Biosciences|October 25, 2016
Effects of a Mutation in the <i>HSPE1</i> Gene Encoding the Mitochondrial Co-chaperonin HSP10 and Its Potential Association with a Neurological and Developmental DisorderAnne S Bie, Paula Fernandez-Guerra, Rune I D Birkler, et al.
Brain : a Journal of Neurology|June 23, 2007
ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiencyRikke K J Olsen, Simon E Olpin, Brage S Andresen, et al.
Pediatric Research|July 22, 2006
Variations in IBD (ACAD8) in children with elevated C4-carnitine detected by tandem mass spectrometry newborn screeningChristina B Pedersen, Claus Bischoff, Ernst Christensen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 24, 2017
Fluxomic evidence for impaired contribution of short-chain acyl-CoA dehydrogenase to mitochondrial palmitate β-oxidation in symptomatic patients with ACADS gene susceptibility variantsAnne-Frédérique Dessein, Monique Fontaine, Marie Joncquel-Chevalier Curt, et al.
Nature Metabolism|October 16, 2025
Interaction of sortilin with apolipoprotein E3 enables neurons to use long-chain fatty acids as alternative metabolic fuelAnna K Greda, Jemila P Gomes, Vanessa Schmidt-Krueger, et al.
Diabetes, Obesity & Metabolism|May 13, 2018
Metformin targets brown adipose tissue in vivo and reduces oxygen consumption in vitroPeter Breining, Jonas B Jensen, Elias I Sundelin, et al.
Nature Communications|July 30, 2025
De novo pyrimidine biosynthesis inhibition synergizes with BCL-X<sub>L</sub> targeting in pancreatic cancerHuan Zhang, Naiara Santana-Codina, Qijia Yu, et al.
Oncogene|August 6, 2022
A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancerMalene Blond Ipsen, Ea Marie Givskov Sørensen, Emil Aagaard Thomsen, et al.
Pageof 21